Treatment of hepatitis delta chronic infection: HBs antigen quantification may help monitoring, and HBs antigen seroconversion could be the ideal ‘end’ point of treatment
Ségolène Brichler, Mashiko Setshedi, Christophe RenouVolume:
55
Year:
2012
Language:
english
DOI:
10.1016/j.jcv.2012.05.015
File:
PDF, 122 KB
english, 2012